Staphylococci are among the leading causes of nosocomial infections. Increasing insusceptibility to β-lactams and the glycopeptides complicates treatment of these infections. This review examines the current status and future perspectives for the therapy of infections caused by Staphylococcus aureus and coagulase-negative staphylococci. © 2007 Elsevier B.V. All rights reserved.
|Journal||International Journal of Antimicrobial Agents|
|Issue number||Suppl. 3|
|Publication status||Published - May 2007|
- antimicrobial resistance
- coagulase-negative staphylococci
- staphylococcus aureus